|
⚲
|
| Keyboard |
| Telemachus Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002152986 |
| Sale | 2026-08-20 (1.5 M Offered, 0.1 M Sold) |
| Fund | |
| Phone | 4125276630 |
| Address | 401 Woodhaven Drive Pittsburgh, PA 15090 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-02 (D) |
| Exemption | 506(b) |
| Minimum | $50,000 |
| Remaining | $1,375,000 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Gregory Hebrank | Executive Officer | |
| Michael Bozik | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Attalus Capital LP
✚
|
PA | |
|
Cox Capital General Partner LLC
✚
|
PA | |
|
Penn Capital Management Co Inc
✚
|
PA | |
|
RTM Asset Management LLC
✚
|
PA | |
|
Turner Investments LP
✚
|
PA | |
|
Lotus Capital Management LLC
✚
|
PA | |
|
Protea Asset Management LLC
✚
|
PA | |
|
Energy Power Management I LLC
✚
|
PA | |
|
Susquehanna Securities LLC
✚
|
PA | |
|
Federated International Securities Corp
✚
|
PA |